AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
HIV AIDS - Is the Nader CD4 Cell Count What Matters?
Everybody in the trial, including those in the original deferred group were offered ART to start by January 1, 2016. They retained 4,436 patients in this additional analysis post 2016. The remaining excess risk was primarily driven by patients that were 35 years of age or less. So it's definitely got me thinking. There still is probably going to spark a lot of research moving forward.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode